Literature DB >> 29314514

Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.

Elina Tan1, Grace Thompson1,2, Charlotta Ekstrom1, Michaela Lucas1,3,4,5.   

Abstract

Non-immediate allergic cutaneous reactions to heparins have been increasingly reported, typically manifesting as large, eczematous plaques at sites of subcutaneous injection. Patients may demonstrate cross-reactivity between unfractionated heparin, low molecular weight heparin and semi-synthetic heparinoids, making finding an alternative difficult. Fondaparinux has been identified as a useful alternative in such patients; here we present the first two documented cases in Australia and a literature review.
© 2018 Royal Australasian College of Physicians.

Entities:  

Keywords:  anticoagulation; hypersensitivity; immunology; low molecular weight heparin; unfractionated heparin; venous thromboembolism

Mesh:

Substances:

Year:  2018        PMID: 29314514     DOI: 10.1111/imj.13659

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  3 in total

1.  Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis.

Authors:  Elena Minenna; Nada Chaoul; Maria Pia Rossi; Lucia Giliberti; Marcello Albanesi; Eustachio Nettis; Maria Pia Foschino Barbaro; Danilo Di Bona; Maria Filomena Caiaffa; Luigi Macchia
Journal:  Postepy Dermatol Alergol       Date:  2021-10-01       Impact factor: 1.664

Review 2.  Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management.

Authors:  Vasileios Patriarcheas; Antonios Pikoulas; Minas Kostis; Andriani Charpidou; Evangelos Dimakakos
Journal:  Cureus       Date:  2020-03-24

3.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.